Cite
Singh ZN, Duong VH, Koka R, et al. High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen. J Hematop. 2018;11(3):67-74doi: 10.1007/s12308-018-0329-z.
Singh, Z. N., Duong, V. H., Koka, R., Zou, Y., Sawhney, S., Tang, L., Baer, M. R., Ambulos, N., El Chaer, F., & Emadi, A. (2018). High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen. Journal of hematopathology, 11(3), 67-74. https://doi.org/10.1007/s12308-018-0329-z
Singh, Zeba N, et al. "High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen." Journal of hematopathology vol. 11,3 (2018): 67-74. doi: https://doi.org/10.1007/s12308-018-0329-z
Singh ZN, Duong VH, Koka R, Zou Y, Sawhney S, Tang L, Baer MR, Ambulos N, El Chaer F, Emadi A. High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen. J Hematop. 2018 Sep;11(3):67-74. doi: 10.1007/s12308-018-0329-z. Epub 2018 Aug 09. PMID: 30294391; PMCID: PMC6171103.
Copy
Download .nbib